FDA Inspection 1191456 — NattoPharma USA, Inc.

NattoPharma USA, Inc. — FEI 3010437741

The FDA completed an inspection of NattoPharma USA, Inc. on Nov 16, 2022 in East Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Food/Cosmetics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Nov 16, 2022
Fiscal Year
2023
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
East Brunswick, NJ (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.